| Pfizer AG - Xalkori 250 mg, Hartkapseln | | 62131 | | 02 | | Xalkori 250 mg | | Hartkapseln | | L01ED01 | | Crizotinib | | 05.03.2012 | | |
| | Composition | | crizotinibum 250 mg, silica colloidalis anhydrica, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum A corresp. natrium 1.05 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Crizotinibum | 250 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Crizotinibum | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Ammoniae Solutio | 30 | | | Calcium Hydrogenophosphate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Per Centum | | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 60 Gélule(s) | 4645.48 | 5068.65 | A | LS | Oui |
|
|
